Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric R. Fedyk
Eric R. Fedyk
Takeda Pharmaceutical Company
Medicine
Internal medicine
Multiple myeloma
Oncology
in patient
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects.
2021
Clinical and Translational Science
Ehsanollah Esfandiari
Mary Chen
Glennda Smithson
Derek Blair
Hélène M. Faessel
John A. Wagner
Lachy McLean
Eric R. Fedyk
Show All
Source
Cite
Save
Citations (1)
Mezagitamab Induces Immunomodulatory Effect in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2020
Blood
Michael Abadier
Jose Estevam
Deborah Berg
Eric R. Fedyk
Show All
Source
Cite
Save
Citations (0)
1